$VNDA старая новость, но интересно. удовлетворили ходатайство об отклонении иска к Компании из-за пзджа при продажах. Но истец может вернуть доработанный иск... А может и ... Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the Federal District Court in Washington D.C. granted Vanda's motion to dismiss a False Claims Act lawsuit filed against the company. On May 19, 2020, Judge Amit P. Mehta granted Vanda's motion to dismiss the lawsuit, concluding that the relator's allegations fail to state a viable claim under the False Claims Act. At the relator's request, the Court will allow an amended complaint in which the relator may attempt to remedy pleading deficiencies. If the relator does replead, Vanda anticipates filing a renewed motion to dismiss.